Researchers discovered a mechanism that stops the body reacting with an excessive immune reaction. This could be the basis for a new treatment.
Most people with allergies have to take medication throughout their life: Their body “thinks” that proteins from the environment are so “strange” that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body “learns” to stop in an overreacting way.
Scientists from the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, from the University of Tokyo, the RIKEN Research Institute in Yokohoma, and from Stanford University recently discovered a mechanism that could be the basis for a new way to handle allergies.
Mast cells play a key role in the disease process in allergies: As a reaction towards an allergen – for example pollen or dust mites – they release big amounts of substances that initiate an inflammatory process. Study leader Hideaki Morita and his team discovered that mast cells are not only “bad guys”, but also have a “good side” (see figure): They release the substance interleukin-2 that induces the production of certain immune cells called T-regulatory (Treg) cells. Treg cells can suppress the allergic inflammatory process in the airways induced by interleukin-10.
It is already known for some time that Treg cells can subdue an excessive immune response and the resulting inflammation. For example, injections with Treg cells prevented autoimmune diseases in mice. However, for Treg cell treatments one needs a large amount of these cells, which is not easy to realise. In the blood, there are just a few of them, and in vitro they are difficult to produce. Using mast cells, Treg cells could be easily produced in the laboratory in large quantities.
“The mechanism that we discovered, could be the basis for a new way to handle allergies,” says Hideaki Morita.
Read more: A possible cure for allergies
The Latest on: Cure for allergies
via Google News
The Latest on: Cure for allergies
- UNMC starts clinical trial on coronavirus treatmenton February 25, 2020 at 7:56 pm
“We urgently need a safe and effective treatment for COVID-19,” said Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases. The federal Centers for Disease ...
- Cleveland Clinic opens Northeast Ohio’s first food allergy centeron February 25, 2020 at 6:51 pm
The Food Allergy Center of Excellence will provide multidisciplinary care for preventing, treating and diagnosing food allergies. The center, located at the Cleveland Clinic Strongsville Family Health ...
- Remdesivir for the treatment of COVID-19: Clinical trials begins at the University of Nebraskaon February 25, 2020 at 5:01 pm
The trial regulatory sponsor is the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. This is the first clinical trial in the United States to ...
- Cleveland Clinic opens NE Ohio’s first food allergy centeron February 25, 2020 at 3:28 pm
“However, oral immunotherapy has ushered in a new era for food allergy patients. We are excited to be able to offer this therapy to carefully selected patients who can benefit from it as a treatment ...
- New treatment for peanut allergies in the Pittsburgh areaon February 25, 2020 at 3:02 pm
A doctor in the Pittsburgh area is one of the few in the country offering a new type of treatment for food allergies.
- New treatment aims to help children with severe peanut allergyon February 25, 2020 at 10:03 am
The new drug is called Palforzia, a pill containing a powder made from peanuts, and it is approved for kids between the ages of 4-17 years old.
- Survival Guide for Allergy Season: Latest Tips According to Shirin Peters, M.D. With Bethany Medical Clinicon February 24, 2020 at 2:47 pm
I often recommend tips and lifestyle changes to my patients in order to help alleviate symptoms by implementing effective at home remedies,” says Shirin Peters, M.D. with Bethany Medical Clinic. Here ...
- Allergy Treatment Drugs Market Trends, Key Profile Analysis, Future Insights, Size Estimation and Global Industry Dynamics By 2026on February 24, 2020 at 1:20 am
Rising incidence of allergic conjunctivitis and rhinitis is expected to propel growth of the global allergy treatment drugs market over the forecast period. For instance, according to the article ...
- DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Childrenon February 22, 2020 at 12:49 am
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has ...
- Allergy drops: A needle-free, customized treatment for chronic allergieson February 20, 2020 at 1:10 pm
Angela Zimmerly suffered with year-round allergies for years. She tried allergy shots, but the inconvenience of taking time off work to drive to her doctor’s office twice a week became too much. She ...
via Bing News